glp-1 weight loss overview Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response GLP-1 weight loss drugs leave

The Lasker Foundation celebrates scientific and medical advances, and that is very important

Key Points: GI symptoms are the most common adverse effects, ranging from expected nausea and vomiting to gastroparesis and, rarely, functional obstruction Delayed gastric emptying has important airway implications and a cautious approach to airway management is warranted Biliary disease is one of the most clinically significant complications, particularly early in treatment and with rapid weight loss Pancreatitis is rare, and current evidence does not support a strong causal relationship EDKA and AKI are uncommon but important to recognize in the right context Conclusions: GLP-1 receptor agonists have transformed the management of diabetes and obesity, with clear benefits in weight loss, glycemic control, and cardiovascular outcomes

With our Diabetes Mellitus Essentials course, you'll learn how to fine-tune your patient's treatment plans, confidently initiate, adjust, and manage insulin regimes, and screen for diabetic complications with total ease

If patients feel unsure about their current dose, or find that it isnt working as expected, they should speak to a clinician

Association between dipeptidyl peptidase-4 inhibitor drugs and risk of acute pancreatitis: a meta-analysis